These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 36377156)
1. Clinico-Haematologic Parameters And Assessment Of Post-Induction Status In Acute Lymphoblastic Leukaemia. Niaz H; Malik HS; Mahmood R; Mehmood A; Zaidi SA; Nisar U J Ayub Med Coll Abbottabad; 2022; 34(3):458-462. PubMed ID: 36377156 [TBL] [Abstract][Full Text] [Related]
2. Cytogenetic Profile Of Acute Lymphoblastic Leukaemia Patients And Its Association With Induction Remission Status. Niaz H; Malik HS; Mahmood R; Mehmood A; Nisar U; Jalil S J Ayub Med Coll Abbottabad; 2022; 34(Suppl 1)(4):S909-S912. PubMed ID: 36550642 [TBL] [Abstract][Full Text] [Related]
3. Response rate of Pakistani children with acute lymphoblastic leukaemia to Medical Research Council acute lymphoblastic leukaemia 97 chemotherapy protocol. Idris M; Farid J; Sarwar J; Ahmed S; Wiqar MA; Badsha S J Ayub Med Coll Abbottabad; 2010; 22(3):8-11. PubMed ID: 22338406 [TBL] [Abstract][Full Text] [Related]
4. Induction Chemotherapy Response in Childhood Acute Lymphoblastic Leukaemia and its Correlation with Cytogenetic and Molecular Features. Rana NA; Mahmood A; Robert HM; Zahir S; Ali I; Riaz S J Coll Physicians Surg Pak; 2022 Nov; 32(11):1430-1434. PubMed ID: 36377010 [TBL] [Abstract][Full Text] [Related]
5. Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial. Vora A; Goulden N; Mitchell C; Hancock J; Hough R; Rowntree C; Moorman AV; Wade R Lancet Oncol; 2014 Jul; 15(8):809-18. PubMed ID: 24924991 [TBL] [Abstract][Full Text] [Related]
6. Rates of laboratory adverse events by course in paediatric leukaemia ascertained with automated electronic health record extraction: a retrospective cohort study from the Children's Oncology Group. Miller TP; Getz KD; Li Y; Demissei BG; Adamson PC; Alonzo TA; Burrows E; Cao L; Castellino SM; Daves MH; Fisher BT; Gerbing R; Grundmeier RW; Krause EM; Lee J; Lupo PJ; Rabin KR; Ramos M; Scheurer ME; Wilkes JJ; Winestone LE; Hawkins DS; Gramatges MM; Aplenc R Lancet Haematol; 2022 Sep; 9(9):e678-e688. PubMed ID: 35870472 [TBL] [Abstract][Full Text] [Related]
7. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children]. Pituch-Noworolska A Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422 [TBL] [Abstract][Full Text] [Related]
8. Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis. Conter V; Valsecchi MG; Buldini B; Parasole R; Locatelli F; Colombini A; Rizzari C; Putti MC; Barisone E; Lo Nigro L; Santoro N; Ziino O; Pession A; Testi AM; Micalizzi C; Casale F; Pierani P; Cesaro S; Cellini M; Silvestri D; Cazzaniga G; Biondi A; Basso G Lancet Haematol; 2016 Feb; 3(2):e80-6. PubMed ID: 26853647 [TBL] [Abstract][Full Text] [Related]
9. Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohort. Essig S; Li Q; Chen Y; Hitzler J; Leisenring W; Greenberg M; Sklar C; Hudson MM; Armstrong GT; Krull KR; Neglia JP; Oeffinger KC; Robison LL; Kuehni CE; Yasui Y; Nathan PC Lancet Oncol; 2014 Jul; 15(8):841-51. PubMed ID: 24954778 [TBL] [Abstract][Full Text] [Related]
10. Out come of induction of remission in undernourished children with acute lymphoblastic leukaemia. Begum M; Jahan S; Tawfique M; Mannan MA Mymensingh Med J; 2012 Oct; 21(4):691-5. PubMed ID: 23134919 [TBL] [Abstract][Full Text] [Related]
11. Induction-remission response in peadiatric acute lymphoblastic leukaemia, Lahore protocol versus UKALL 2011 interim guidelines. Khan S; Anwar S; Latif MF; Farooq A; Faizan M J Pak Med Assoc; 2020 Apr; 70(4):591-596. PubMed ID: 32296200 [TBL] [Abstract][Full Text] [Related]
12. Treatment of elderly patients with acute lymphoblastic leukaemia using a paediatric-based protocol. Martell MP; Atenafu EG; Minden MD; Schuh AC; Yee KW; Schimmer AD; Gupta V; Brandwein JM Br J Haematol; 2013 Nov; 163(4):458-64. PubMed ID: 24033272 [TBL] [Abstract][Full Text] [Related]
13. [Lineage switch - conversion of acute lymphoblastic leukaemia to acute myeloid leukaemia in 4 years old girl]. Szpecht D; Derwich K; Wachowiak J; Konatkowska B; Dworacki G Med Wieku Rozwoj; 2008; 12(4 Pt 2):1041-4. PubMed ID: 19531823 [TBL] [Abstract][Full Text] [Related]
14. Pulse therapy with vincristine and dexamethasone for childhood acute lymphoblastic leukaemia (CCCG-ALL-2015): an open-label, multicentre, randomised, phase 3, non-inferiority trial. Yang W; Cai J; Shen S; Gao J; Yu J; Hu S; Jiang H; Fang Y; Liang C; Ju X; Wu X; Zhai X; Tian X; Wang N; Liu A; Jiang H; Jin R; Sun L; Yang M; Leung AWK; Pan K; Zhang Y; Chen J; Zhu Y; Zhang H; Li C; Yang JJ; Cheng C; Li CK; Tang J; Zhu X; Pui CH Lancet Oncol; 2021 Sep; 22(9):1322-1332. PubMed ID: 34329606 [TBL] [Abstract][Full Text] [Related]
15. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol]. Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166 [TBL] [Abstract][Full Text] [Related]
16. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Pieters R; Schrappe M; De Lorenzo P; Hann I; De Rossi G; Felice M; Hovi L; LeBlanc T; Szczepanski T; Ferster A; Janka G; Rubnitz J; Silverman L; Stary J; Campbell M; Li CK; Mann G; Suppiah R; Biondi A; Vora A; Valsecchi MG Lancet; 2007 Jul; 370(9583):240-250. PubMed ID: 17658395 [TBL] [Abstract][Full Text] [Related]
17. The changing burden of long-term health outcomes in survivors of childhood acute lymphoblastic leukaemia: a retrospective analysis of the St Jude Lifetime Cohort Study. Mulrooney DA; Hyun G; Ness KK; Bhakta N; Pui CH; Ehrhardt MJ; Krull KR; Crom DB; Chemaitilly W; Srivastava DK; Relling MV; Jeha S; Green DM; Yasui Y; Robison LL; Hudson MM Lancet Haematol; 2019 Jun; 6(6):e306-e316. PubMed ID: 31078468 [TBL] [Abstract][Full Text] [Related]
18. Improved outcome of acute lymphoblastic leukaemia treated by delayed intensification in Hong Kong children: HKALL97 study. Li CK; Chik KW; Ha SY; Lee AC; Yuen HL; Ling SC; Lee V; Chan GC; Shing MM; Chan LC; Ng MH Hong Kong Med J; 2006 Feb; 12(1):33-9. PubMed ID: 16495587 [TBL] [Abstract][Full Text] [Related]
19. Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study. Pui CH; Pei D; Coustan-Smith E; Jeha S; Cheng C; Bowman WP; Sandlund JT; Ribeiro RC; Rubnitz JE; Inaba H; Bhojwani D; Gruber TA; Leung WH; Downing JR; Evans WE; Relling MV; Campana D Lancet Oncol; 2015 Apr; 16(4):465-74. PubMed ID: 25800893 [TBL] [Abstract][Full Text] [Related]
20. Phase II study of intensive post-remission chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia and lymphoblastic lymphoma: Japan Clinical Oncology Group Study, JCOG9402. Azuma T; Tobinai K; Takeyama K; Shibata T; Hidaka M; Kurosawa M; Kasai M; Chou T; Fukushima N; Mukai K; Tsukasaki K; Shimoyama M; Jpn J Clin Oncol; 2012 May; 42(5):394-404. PubMed ID: 22422899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]